Sundial: Analysts Expect Positive EBITDA For Q3 2021

Sundial Growers (NASDAQ: SNDL) announced that they will be reporting their third quarter financials after the markets close on November 10th.

Analysts have a consensus US$0.71 12-month price target on the company, via a total of 5 analysts, with 4 analysts having hold ratings, and one other analyst has a sell rating on the company. The street high comes from ATB Capital Markets with a US$0.80 price target, and the lowest target comes from Cantor Fitzgerald with a US$0.00 price target.

Only 4 analysts have revenue estimates for the third quarter. The mean between all 4 is C$16.48 million; this number has been remained flat since the start of May. The street high is C$19.1 million while the lowest sits at C$11.40 million.

Only two analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 35.3%, with this number being flat at the start of May. Street high is a 40.6% estimate and the lowest sits at 30%.

Onto EBITDA estimates, there are currently only 3 analysts who have third-quarter EBITDA estimates. The mean is currently C$0.97 million, with this number being slightly higher than at the start of May. Street high sits at C$2 million EBITDA and the lowest being a (C$0.4) million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

Why Industrial Demand Is Changing the Silver Market | David Morgan

Gold and Silver Delivery Is Exposing the Paper Market | Andy Schectman

Recommended

Nations Royalty Names Derrick Pattenden As President And CEO

First Phosphate Receives US$530,000 Pre-Payment Under Offtake Agreement

Related News

Trulieve Sees Consensus Price Target Tumble After Cutting Guidance

Trulieve Cannabis (CSE: TRUL) reported its second quarter financial results on Wednesday. The company announced...

Thursday, August 11, 2022, 04:39:00 PM

Organigram: Canaccord Lowers Price Target To $2.50

Yesterday, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) reported their fourth quarter financials. The company announced...

Tuesday, December 1, 2020, 11:17:00 AM

CloudMD Gets Price Target Cut By Canaccord Genuity

On Monday CloudMD Software & Services Inc. (TSXV: DOC) reported its fourth quarter results for...

Wednesday, May 4, 2022, 03:06:00 PM

Uranium Royalty Corp: Canaccord Lifts Price Target To $4.25

Uranium Royalty Corp (TSXV: URC) recently closed their C$37 million financing, allowing Canaccord Genuity to...

Saturday, May 22, 2021, 02:04:00 PM

Canaccord Raises CloudMD Price Target To $1.75 Following Financial Results

On Monday, CloudMD Software & Services (TSXV: DOC) reported its second-quarter financials. CloudMD’s revenue was...

Thursday, September 3, 2020, 02:37:00 PM